396 related articles for article (PubMed ID: 30922953)
1. Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection.
Kye YC; Park SM; Shim BS; Firdous J; Kim G; Kim HW; Ju YJ; Kim CG; Cho CS; Kim DW; Cho JH; Song MK; Han SH; Yun CH
Acta Biomater; 2019 May; 90():362-372. PubMed ID: 30922953
[TBL] [Abstract][Full Text] [Related]
2. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
[TBL] [Abstract][Full Text] [Related]
3. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
4. Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections.
Zhang Y; Guo X; Guo M; Chen X; Li B; Yu J; Gu T; Kong W; Wu Y
Immunol Res; 2019 Oct; 67(4-5):398-407. PubMed ID: 31773490
[TBL] [Abstract][Full Text] [Related]
5. Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.
Kong IG; Sato A; Yuki Y; Nochi T; Takahashi H; Sawada S; Mejima M; Kurokawa S; Okada K; Sato S; Briles DE; Kunisawa J; Inoue Y; Yamamoto M; Akiyoshi K; Kiyono H
Infect Immun; 2013 May; 81(5):1625-34. PubMed ID: 23460513
[TBL] [Abstract][Full Text] [Related]
6. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.
Yamamoto M; McDaniel LS; Kawabata K; Briles DE; Jackson RJ; McGhee JR; Kiyono H
Infect Immun; 1997 Feb; 65(2):640-4. PubMed ID: 9009325
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
[TBL] [Abstract][Full Text] [Related]
10. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
[TBL] [Abstract][Full Text] [Related]
11. Broad protective immune responses elicited by bacterium-like particle-based intranasal pneumococcal particle vaccine displaying PspA2 and PspA4 fragments.
Lu J; Guo J; Wang D; Yu J; Gu T; Jiang C; Kong W; Wu Y
Hum Vaccin Immunother; 2019; 15(2):371-380. PubMed ID: 30235046
[TBL] [Abstract][Full Text] [Related]
12. Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.
Salcedo-Rivillas C; Debrie AS; Miyaji EN; Ferreira JM; Raw I; Locht C; Ho PL; Mielcarek N; Oliveira ML
Clin Vaccine Immunol; 2014 Jul; 21(7):972-81. PubMed ID: 24807055
[TBL] [Abstract][Full Text] [Related]
13. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
[TBL] [Abstract][Full Text] [Related]
14. Role of antibodies and IL17-mediated immunity in protection against pneumococcal otitis media.
Habets MN; van Selm S; van Opzeeland FJ; Simonetti E; Hermans PWM; de Jonge MI; Diavatopoulos DA
Vaccine; 2016 Nov; 34(48):5968-5974. PubMed ID: 27771185
[TBL] [Abstract][Full Text] [Related]
15. A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A.
Yamamoto M; Briles DE; Yamamoto S; Ohmura M; Kiyono H; McGhee JR
J Immunol; 1998 Oct; 161(8):4115-21. PubMed ID: 9780183
[TBL] [Abstract][Full Text] [Related]
16. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.
Arulanandam BP; Lynch JM; Briles DE; Hollingshead S; Metzger DW
Infect Immun; 2001 Nov; 69(11):6718-24. PubMed ID: 11598043
[TBL] [Abstract][Full Text] [Related]
17. Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.
Oliveira ML; Miyaji EN; Ferreira DM; Moreno AT; Ferreira PC; Lima FA; Santos FL; Sakauchi MA; Takata CS; Higashi HG; Raw I; Kubrusly FS; Ho PL
PLoS One; 2010 May; 5(5):e10863. PubMed ID: 20523738
[TBL] [Abstract][Full Text] [Related]
18. Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity.
Wagner-Muñiz DA; Haughney SL; Kelly SM; Wannemuehler MJ; Narasimhan B
Front Immunol; 2018; 9():325. PubMed ID: 29599766
[No Abstract] [Full Text] [Related]
19. Intranasal Immunization with the Commensal
Shekhar S; Khan R; Schenck K; Petersen FC
Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
[No Abstract] [Full Text] [Related]
20. Enhanced protective responses to a serotype-independent pneumococcal vaccine when combined with an inactivated influenza vaccine.
Babb R; Chen A; Ogunniyi AD; Hirst TR; Kara EE; McColl SR; Alsharifi M; Paton JC
Clin Sci (Lond); 2017 Jan; 131(2):169-180. PubMed ID: 27885052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]